Manually-actuated reduced pressure treatment system with audible leak indicator
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-035/00
A61M-001/00
A61F-013/00
A61B-005/00
출원번호
US-0156256
(2014-01-15)
등록번호
US-9907889
(2018-03-06)
발명자
/ 주소
Locke, Christopher Brian
Coulthard, Richard Daniel John
Whyte, David George
출원인 / 주소
KCI Licensing, Inc.
인용정보
피인용 횟수 :
0인용 특허 :
88
초록▼
Illustrative embodiments of new and useful systems and methods for reduced-pressure therapy are described. One example embodiment is a manually-actuated pump for applying reduced-pressure therapy. The pump generally comprises a charging chamber, a regulated chamber, and a regulator passage between t
Illustrative embodiments of new and useful systems and methods for reduced-pressure therapy are described. One example embodiment is a manually-actuated pump for applying reduced-pressure therapy. The pump generally comprises a charging chamber, a regulated chamber, and a regulator passage between the charging chamber and the regulated chamber. A valve body controls fluid communication through the regulator passage, and a regulator spring may be engaged with the valve body to bias the valve body against a differential between a pressure in the regulated chamber and an ambient pressure. The regulator passage may have a bore size adapted deflect the valve body to cause an audible indication of a leak.
대표청구항▼
1. A manually-actuated pump for applying reduced-pressure therapy, comprising: a charging chamber configured to provide a first pressure;a regulated chamber configured to provide a second pressure that is greater than the first pressure and less than ambient pressure;a regulator passage between the
1. A manually-actuated pump for applying reduced-pressure therapy, comprising: a charging chamber configured to provide a first pressure;a regulated chamber configured to provide a second pressure that is greater than the first pressure and less than ambient pressure;a regulator passage between the charging chamber and the regulated chamber;a valve body adapted to control fluid communication through the regulator passage;a regulator spring engaged with the valve body to bias the valve body against a differential between a pressure in the regulated chamber and an ambient pressure; andan outlet port coupled to the regulated chamber;wherein the regulator passage has a bore size adapted to deflect the valve body to cause an audible indication of a leak that exceeds a predetermined threshold. 2. The manually-actuated pump of claim 1, wherein the bore size of the regulator passage is in a range of about 1 mm to about 1.5 mm. 3. The manually-actuated pump of claim 2, further comprising a conduit coupled to the outlet port, wherein the conduit has a lumen of about 1.2 mm. 4. The manually-actuated pump of claim 3, further comprising a conduit coupled to the outlet port, wherein the predetermined threshold is 0.8 L/min. 5. The manually-actuated pump of claim 1, wherein the regulator passage has a bore size adapted to deflect the valve body less than 0.1 mm. 6. The manually-actuated pump of claim 1, wherein: the valve body is in a closed position when the pressure within the regulated chamber is less than or equal to a desired therapy pressure; andthe valve body is in an open position when the pressure within the regulated chamber is greater than the desired therapy pressure. 7. The manually-actuated pump of claim 1, wherein: the first pressure is about −150 mm Hg; andthe second pressure is about −125 mm Hg. 8. A reduced pressure treatment apparatus comprising: a piston chamber having a closed end;a piston disposed within the piston chamber and being movable between an extended position and a compressed position;a charging chamber disposed between the piston and the closed end;a biasing member adapted to bias the piston toward the extended position;a valve member adapted to allow fluid to exit the charging chamber as the piston moves toward the compressed position and to prevent fluid from entering the charging chamber as the piston moves toward the extended position;a regulated chamber;a passage between the regulated chamber and the charging chamber; anda regulator member configured to regulate fluid communication through the passage;wherein the passage has a bore size adapted to deflect the regulator member to cause an audible indication of a leak greater than a predetermined leak threshold. 9. The apparatus of claim 8, wherein the bore size of the passage is in a range of about 1 mm to about 1.5 mm. 10. The apparatus of claim 9, further comprising a conduit coupled to the regulated chamber, wherein the conduit has a lumen of about 1.2 mm. 11. The apparatus of claim 10, further comprising a conduit coupled to the regulated chamber, wherein the predetermined leak threshold is about 0.8 L/min. 12. The apparatus of claim 8, wherein: the regulator member closes the passage to prevent fluid communication through the passage when pressure in the regulated chamber is less than or equal to a desired therapy pressure; andthe regulator member opens the passage to allow fluid communication through the passage when pressure in the regulated chamber is greater than the desired therapy pressure. 13. The apparatus of claim 8, wherein the regulator member further comprises: a valve seat disposed adjacent the passage; anda valve body capable of engaging the valve seat to substantially reduce fluid communication through the passage. 14. The apparatus of claim 8, wherein: the charging chamber stores a first pressure;the regulated chamber stores a second pressure;the first pressure is less than the second pressure; andthe first pressure and the second pressure are less than an ambient pressure. 15. The apparatus of claim 14, wherein: the first pressure is about −150 mm Hg; andthe second pressure is about −125 mm Hg. 16. The apparatus of claim 9, wherein the biasing member is a piston spring. 17. A reduced pressure treatment apparatus comprising: a charging chamber adapted to store a first pressure less than an ambient pressure;a regulated chamber adapted to store a second pressure less than the ambient pressure, the first pressure being less than the second pressure;a conduit adapted to provide fluid communication between the regulated chamber and the charging chamber; anda regulator member operably associated with the conduit to prevent fluid communication through the conduit when the second pressure is less than or equal to a desired therapy pressure and to allow fluid communication through the conduit when the second pressure exceeds the desired therapy pressure;wherein the conduit has a bore size adapted to deflect the regulator member to cause an audible indication of a leak greater than a leak threshold. 18. The apparatus of claim 17, further comprising an electric pump to deliver a reduced pressure to the charging chamber. 19. The apparatus of claim 17, further comprising a manually-actuated pump to deliver a reduced pressure to the charging chamber. 20. The apparatus of claim 17, wherein the regulator member further comprises: a valve seat disposed adjacent the conduit; anda valve body capable of engaging the valve seat to substantially reduce fluid communication through the conduit. 21. The apparatus of claim 20, further comprising: a spring operably associated with the valve body to urge the valve body toward an open position to allow fluid communication through the conduit. 22. The apparatus of claim 17, wherein: the first pressure is about −150 mm Hg; andthe second pressure is about −125 mm Hg. 23. A reduced pressure treatment system comprising: a manifold adapted to be positioned at a tissue site;a regulated chamber in fluid communication with the manifold and adapted to store a desired therapy pressure, wherein the desired therapy pressure is less than ambient pressure;a charging chamber adapted to store a charging pressure that is less than the desired therapy pressure;a passage adapted to provide fluid communication between the regulated chamber and the charging chamber; anda valve body operably associated with the passage to substantially reduce fluid communication through the passage when a pressure in the regulated chamber is less than or equal to the desired therapy pressure and to allow fluid communication through the passage when the pressure in the regulated chamber exceeds the desired therapy pressure;wherein the passage has a bore size adapted to deflect the valve body to cause an audible indication of a leak greater than a leak threshold. 24. The system of claim 23, wherein: the desired therapy pressure is about −125 mm Hg; andthe charging pressure is about −150 mm Hg. 25. The system of claim 23, further comprising an electric pump to deliver the charging pressure to the charging chamber. 26. The system of claim 23, further comprising a manually-actuated pump to deliver the charging pressure to the charging chamber. 27. The system of claim 23, wherein the valve body is configured to engage a valve seat adjacent the passage to substantially reduce fluid communication through the passage. 28. The system of claim 23, further comprising: a spring operably associated with the valve body to urge the valve body toward an open position, the valve body in the open position allowing fluid communication through the passage. 29. A method of providing reduced pressure treatment to a tissue site, the method comprising: storing a charging pressure within a charging chamber;delivering a desired therapy pressure from a regulated chamber to the tissue site, wherein the desired therapy pressure is stored in the regulated chamber and is less than atmospheric pressure;when a pressure within the regulated chamber exceeds the desired therapy pressure, reducing the pressure within the regulated chamber by allowing fluid communication between the charging chamber and the regulated chamber; andproviding an audible indication of a leak greater than a leak threshold. 30. The method of claim 29, further comprising: selectively blocking a conduit between the charging chamber and the regulated chamber to prevent fluid communication between the charging chamber and the regulated chamber. 31. The method of claim 29, further comprising: charging the charging chamber by manually reducing a volume of the charging chamber and then allowing the volume of the charging chamber to expand.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (88)
Ward William J. (Hull GBX) Shorthouse Joanne (Hull GBX), Adhesive dressing for retaining a cannula on the skin.
Errede Louis A. (North Oaks MN) Stoesz James D. (St. Paul MN) Winter ; deceased George D. (late of St. Paul MN by Jenny Upton ; personal representative), Composite wound dressing.
Todd Robert J. (Salt Lake City UT) Yagge Jaime E. (Salt Lake City UT) Lowe James E. (Durham NC) Wonder Terry M. (Salt Lake City UT), Medical suction apparatus.
Ferdman Ariel (12 Hillside Ave. Melrose MA 02176) Kuo Jing-wen (Boxboro MA) Miller David (Brookline MA) Pinsky Vladimir (Brighton MA) Richards William D. (Medway MA) Swann David (Cambridge MA), Method and device for wound closure.
Moriuchi Yousuke (Fujinomiya JPX) Ishida Toshinobu (Fujinomiya JPX) Kousai Tadashi (Fujinomiya JPX), Method of securing a catheter body to a human skin surface.
Luheshi Abdul B. N. (Hull GB3) Smalley Robert K. (Urmston GB3) Kennewell Peter D. (Okus GB3) Westwood Robert (Kingston Bagpuize GB3), Process for the preparation of azabicyclo compounds.
Kashmer James S. (Budd Lake NJ) Klimbach John K. (Wayne NJ) Vendetti Randall P. (Lincoln Park NJ), Suction canister with unitary shut-off valve and filter features.
Richmond James W. (Kalamazoo MI) Tice Robert G. (Portage MI) Booth ; III William M. (Paw Paw MI), Vacuum wound drainage system and lipids baffle therefor.
McNeil Charles B. (5960 Arbour Ave. Edina MN 55436) McEvoy Thomas J. (13103 Baker Trail Minnetonka MN 55343), Wearable, variable rate suction/collection device.
Lock Peter M. (327 Lordswood La. Petrosa ; Walderslade ; Chatham ; Kent GB2) Webb David R. (9 Lambourn Way Lordwood ; Chatham ; Kent GB2), Wound dressing materials.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.